- Research works
- 23 ▼ 13% vs 2013–17
- Citations
- 535 23.0 per fractional work
- Top-10% rate
- 9.5% record average 16.5%
- Open access
- 37% world 28%
Not ranked overall: Boehringer Ingelheim (Belgium) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 74.9×. Every wedge is a field page.
Which keywords describe research at Boehringer Ingelheim (Belgium)?
By fractional works in all years, weighted toward what it does more of than the world: Fibrosis, Clinical Trials, Epithelial-Mesenchymal Transition, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, TGF-ß, Treatment and Regeneration.
- Stem Cell Regulation
- Pulmonary Drug Delivery
- Inhaler Devices
- Translational Research
- Nanoparticles
- ALK Inhibitors
- Regenerative Medicine
- Treatment Guidelines
- Diagnosis
- Treatment
- Interstitial Lung Disease
- Epithelial-Mesenchymal Transition
- Fibrosis
- Epidemiology
- Clinical Trials
- Idiopathic Pulmonary Fibrosis
- TGF-ß
- Regeneration
- Chemotherapy
- Inflammation
- Targeted Therapy
- EGFR Mutations
- Patient Safety
- Breast Cancer
- Mesenchymal Stem Cells
- Regulatory Challenges
- Vaccine Development
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 27 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 27 words, with their numbers
- Epidemiology3▲ 2.7×14 topics
- Fibrosis2▲ 55×4 topics
- Clinical Trials2▲ 16×4 topics
- Epithelial-Mesenchymal Transition2▲ 104×3 topics
- Idiopathic Pulmonary Fibrosis2▲ 220×1 topic
- Interstitial Lung Disease2▲ 161×2 topics
- TGF-ß2▲ 50×1 topic
- Treatment2▲ 6.1×10 topics
- Regeneration2▲ 39×4 topics
- Diagnosis2▲ 6.2×11 topics
- Chemotherapy1▲ 7.7×5 topics
- Treatment Guidelines1▲ 27×2 topics
- Inflammation1▲ 2.1×8 topics
- Regenerative Medicine1▲ 25×2 topics
- Targeted Therapy1▲ 24×2 topics
- ALK Inhibitors1▲ 84×1 topic
- EGFR Mutations1▲ 84×1 topic
- Nanoparticles1▲ 3.5×2 topics
- Patient Safety1▲ 40×2 topics
- Translational Research1▲ 135×2 topics
- Breast Cancer1▲ 15×2 topics
- Inhaler Devices1▲ 147×1 topic
- Mesenchymal Stem Cells1▲ 37×2 topics
- Pulmonary Drug Delivery1▲ 147×1 topic
- Regulatory Challenges1▲ 55×1 topic
- Stem Cell Regulation1▲ 187×1 topic
- Vaccine Development1▲ 14×3 topics
Which research topics does Boehringer Ingelheim (Belgium) publish most on?
By volume in 2022–2025: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Respiratory viral infections research, Mesenchymal stem cell research and Tendon Structure and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 0 works
- 2 Respiratory viral infections research Epidemiology 0 works
- 3 Mesenchymal stem cell research Genetics 0 works
- 4 Tendon Structure and Treatment Orthopedics and Sports Medicine 0 works
- 5 Immune responses and vaccinations Immunology 0 works
- 6 Analytical Methods in Pharmaceuticals Analytical Chemistry 0 works
- 7 Veterinary Equine Medical Research Equine 0 works
- 8 Pneumonia and Respiratory Infections Epidemiology 0 works
- 9 Veterinary Orthopedics and Neurology Small Animals 0 works
- 10 Heart Failure Treatment and Management Cardiology and Cardiovascular Medicine 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Boehringer Ingelheim (Belgium)'s research output changed?
Output in 2018–2022 was 13% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Brussels
- Vrije Universiteit Brussel
- Université Libre de Bruxelles
- Cliniques Universitaires Saint-Luc
- Erasmus Hospital
- European Commission
- UCLouvain Saint-Louis Brussels
- European Union of Medical Specialists
- European Union
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.